Outcome | Treatment group | Control group | P-value |
---|---|---|---|
Tumor responseb | n = 29 | n = 53 | 0.61 |
 Complete response | 2 (7) | 6 (11.3) |  |
 Partial response | 9 (31) | 5 (9.4) |  |
 Stable disease | 12 (41.3) | 35 (66.1) |  |
 Progressive disease | 6 (20.7) | 7 (13.2) |  |
Portal vein tumor thrombus responseb | n = 29 | n = 53 | < 0.001 |
 Grade 3 | 6 (20.7) | 1 (1.9) |  |
 Grade 2 | 15 (51.7) | 6 (11.3) |  |
 Grade 1 | 6(20.7) | 10 (18.9) |  |
 Grade 0 | 2 (6.9) | 36 (67.9) |  |
Overall survival (%) | n = 31 | n = 57 | 0.001 |
 At 3-months | 90.3 | 59.6 |  |
 At 6-months | 64.5 | 29.8 |  |
 At 12-months | 41.9 | 10.6 |  |